Hartmann A - Search Results

1

Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on Prognosis.

Fasching PA, Yadav S, Hu C, Wunderle M, Häberle L, Hart SN, Rübner M, Polley EC, Lee KY, Gnanaolivu RD, Hadji P, Hübner H, Tesch H, Ettl J, Overkamp F, Lux MP, Ekici AB, Volz B, Uhrig S, Lüftner D, Wallwiener M, Müller V, Belleville E, Untch M, Kolberg HC, Beckmann MW, Reis A, Hartmann A, Janni W, Wimberger P, Taran FA, Fehm TN, Wallwiener D, Brucker SY, Schneeweiss A, Hartkopf AD, Couch FJ. Fasching PA, et al. Among authors: hartmann a. J Clin Oncol. 2021 May 20;39(15):1619-1630. doi: 10.1200/JCO.20.01200. Epub 2021 Mar 29. J Clin Oncol. 2021. PMID: 33780288 Free PMC article.

2

p53 gene mutations in breast cancers in midwestern US women: null as well as missense-type mutations are associated with poor prognosis.

Saitoh S, Cunningham J, De Vries EM, McGovern RM, Schroeder JJ, Hartmann A, Blaszyk H, Wold LE, Schaid D, Sommer SS, et al. Saitoh S, et al. Among authors: hartmann a. Oncogene. 1994 Oct;9(10):2869-75. Oncogene. 1994. PMID: 8084591

3

Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value.

Kovach JS, Hartmann A, Blaszyk H, Cunningham J, Schaid D, Sommer SS. Kovach JS, et al. Among authors: hartmann a. Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1093-6. doi: 10.1073/pnas.93.3.1093. Proc Natl Acad Sci U S A. 1996. PMID: 8577720 Free PMC article.

4

Microsatellite instability predicts poor short-term survival in patients with advanced breast cancer after high-dose chemotherapy and autologous stem-cell transplantation.

Wild PJ, Reichle A, Andreesen R, Röckelein G, Dietmaier W, Rüschoff J, Blaszyk H, Hofstädter F, Hartmann A. Wild PJ, et al. Among authors: hartmann a. Clin Cancer Res. 2004 Jan 15;10(2):556-64. doi: 10.1158/1078-0432.ccr-0601-03. Clin Cancer Res. 2004. PMID: 14760077

5

Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors.

Klopocki E, Kristiansen G, Wild PJ, Klaman I, Castanos-Velez E, Singer G, Stöhr R, Simon R, Sauter G, Leibiger H, Essers L, Weber B, Hermann K, Rosenthal A, Hartmann A, Dahl E. Klopocki E, et al. Among authors: hartmann a. Int J Oncol. 2004 Sep;25(3):641-9. Int J Oncol. 2004. PMID: 15289865

6

Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients.

Fasching PA, Loehberg CR, Strissel PL, Lux MP, Bani MR, Schrauder M, Geiler S, Ringleff K, Oeser S, Weihbrecht S, Schulz-Wendtland R, Hartmann A, Beckmann MW, Strick R. Fasching PA, et al. Among authors: hartmann a. Breast Cancer Res Treat. 2008 Nov;112(1):89-98. doi: 10.1007/s10549-007-9822-2. Epub 2007 Nov 30. Breast Cancer Res Treat. 2008. PMID: 18049890

7

Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer.

Schrauder M, Frank S, Strissel PL, Lux MP, Bani MR, Rauh C, Sieber CC, Heusinger K, Hartmann A, Schulz-Wendtland R, Strick R, Beckmann MW, Fasching PA. Schrauder M, et al. Among authors: hartmann a. J Cancer Res Clin Oncol. 2008 Aug;134(8):873-82. doi: 10.1007/s00432-008-0355-9. Epub 2008 Feb 9. J Cancer Res Clin Oncol. 2008. PMID: 18264724

8

The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer.

Bektas N, Noetzel E, Veeck J, Press MF, Kristiansen G, Naami A, Hartmann A, Dimmler A, Beckmann MW, Knüchel R, Fasching PA, Dahl E. Bektas N, et al. Among authors: hartmann a. Breast Cancer Res. 2008;10(4):R58. doi: 10.1186/bcr2117. Epub 2008 Jul 15. Breast Cancer Res. 2008. PMID: 18627608 Free PMC article.

9

Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients.

Harbeck N, Nimmrich I, Hartmann A, Ross JS, Cufer T, Grützmann R, Kristiansen G, Paradiso A, Hartmann O, Margossian A, Martens J, Schwope I, Lukas A, Müller V, Milde-Langosch K, Nährig J, Foekens J, Maier S, Schmitt M, Lesche R. Harbeck N, et al. Among authors: hartmann a, hartmann o. J Clin Oncol. 2008 Nov 1;26(31):5036-42. doi: 10.1200/JCO.2007.14.1697. Epub 2008 Aug 18. J Clin Oncol. 2008. PMID: 18711169

10

Early aberrant insulin-like growth factor signaling in the progression to endometrial carcinoma is augmented by tamoxifen.

Strissel PL, Ellmann S, Loprich E, Thiel F, Fasching PA, Stiegler E, Hartmann A, Beckmann MW, Strick R. Strissel PL, et al. Among authors: hartmann a. Int J Cancer. 2008 Dec 15;123(12):2871-9. doi: 10.1002/ijc.23900. Int J Cancer. 2008. PMID: 18814240 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,389 results

Search Page